The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Automatic Immunohistochemical Staining Instrument Market From 2026 To 2030?
The automatic immunohistochemical staining instrument market has experienced substantial growth in recent years. Projections indicate an expansion from $1.3 billion in 2025 to $1.4 billion in 2026, driven by a compound annual growth rate (CAGR) of 7.1%. Historically, this expansion has been influenced by factors including an increase in cancer diagnostic testing volumes, the development of pathology laboratory infrastructure, greater reliance on immunohistochemistry in disease diagnosis, the expanding availability of automated laboratory instruments, and a heightened demand for reproducible diagnostic results.
The market for automatic immunohistochemical staining instruments is projected to experience substantial expansion in the coming years. This market is anticipated to reach $1.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth during the forecast period include the expanding uptake of precision oncology diagnostics, increased investments in digital pathology platforms, a heightened demand for laboratory automation, the broadened development of companion diagnostics, and a greater emphasis on personalized medicine approaches. Key trends expected during the same period encompass the rising adoption of fully automated IHC staining systems, an increasing need for high-throughput diagnostic workflows, the growing integration of digital pathology compatibility, the expansion of standardized and reproducible staining protocols, and an enhanced focus on workflow efficiency within laboratories.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24164&type=smp
Which Major Drivers Are Influencing The Expansion Of The Automatic Immunohistochemical Staining Instrument Market?
The increasing occurrence of chronic diseases is anticipated to drive the expansion of the automatic immunohistochemical staining instrument market moving ahead. Chronic illnesses are defined as enduring health issues that typically advance gradually and necessitate continuous care. These encompass conditions such as diabetes, cardiac ailments, high blood pressure, joint inflammation, persistent respiratory illnesses, various cancers, and excess weight. The rising incidence of these diseases stems from shifts in lifestyle, poor dietary habits, and insufficient physical movement, all of which lead to enduring health challenges. Automatic immunohistochemical staining instruments improve diagnostic accuracy through precise and effective tissue analysis, rendering them crucial for identifying chronic diseases. These instruments minimize manual work using rapid, automated staining procedures, thereby boosting diagnostic precision and facilitating earlier disease discovery. For example, in June 2024, data from the National Health Service, a UK government body, revealed that 3,615,330 people registered with a general practitioner (GP) had been diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023. This represented an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the expanding occurrence of chronic diseases is fueling the development of the automatic immunohistochemical staining instrument market.
How Is The Automatic Immunohistochemical Staining Instrument Market Categorized Across Its Segment Groups?
The automatic immunohistochemical staining instrument market covered in this report is segmented –
1) By Product Type: Fully Automated Stainers, Semi-Automated Stainers, Manual Stainers
2) By Technology: Slide Staining, Tissue Staining, Fluorescent Staining
3) By Consumables: Antibodies, Staining Kits, Slides, Coverslips
4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases
5) By End-User: Hospitals, Diagnostic Laboratories, Academic Institutes, Research Laboratories
Subsegments:
1) By Fully Automated Stainers: Compact Automated Stainers, High-Throughput Stainers, Benchtop Automated Stainers
2) By Semi-Automated Stainers: Programmable Stainers, Timer-Based Stainers, Hybrid Stainers
3) By Manual Stainers: Dip-Type Manual Stainers, Rotary Manual Stainers, Handheld Staining Kits
Which Trends Are Shaping The Automatic Immunohistochemical Staining Instrument Market?
Leading companies in the automatic immunohistochemical staining instrument market are concentrating on developing advanced solutions, such as antibody alternative reagents, to improve the accuracy, efficiency, and versatility of tissue analysis while simultaneously lowering costs and boosting reproducibility. An antibody alternative reagent refers to a non-antibody molecule, for example, an aptamer, affirmer, or antibody mimetic, which can specifically bind to target antigens and is utilized instead of traditional antibodies in research, diagnostic, or therapeutic applications. For instance, in March 2023, Aptamer Group plc, a UK-based biotechnology company, introduced Optimer-Fc, a novel reagent solution for automated immunohistochemistry (IHC) workflows. Optimer-Fc serves as an innovative antibody alternative for immunohistochemistry, extending the scope of target detection and refining assay selectivity. It integrates effortlessly into automated immunohistochemistry (IHC) workflows to precisely identify both established and emerging biomarkers.
Which Firms Are Influencing Competition In The Automatic Immunohistochemical Staining Instrument Market?
Major companies operating in the automatic immunohistochemical staining instrument market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Agilent Technologies, Leica Biosystems, Sakura Finetek, Olympus Corporation, Biocare Medical, Celnovte Biotechnology Co. Ltd., BioGenex Laboratories, Diagnostic BioSystems, ADS Biotec, Fuzhou Maixin Biotech Co. Ltd., Shenzhen Dartmon Biotechnology Co. Ltd., Ventana Medical Systems, Dako (Agilent Pathology), Nichirei Biosciences Inc., Abcam plc, Bio-Rad Laboratories, Milestone Medical, Medite GmbH
Get The Full Automatic Immunohistochemical Staining Instrument Market Report:
Which Region Dominates The Automatic Immunohistochemical Staining Instrument Market By Market Share?
North America was the largest region in the automatic immunohistochemical staining instrument market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automatic immunohistochemical staining instrument market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Automatic Immunohistochemical Staining Instrument Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=24164&type=smp
Browse Through More Reports Similar to the Global Automatic Immunohistochemical Staining Instrument Market 2026, By The Business Research Company
Immunohematology Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Immunofluorescence Assay Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report
Immunohistochemistry Ihc Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model